AZ’s ‘Long Shot’ COVID-19 Trial Of Diabetes Drug Farxiga Fails

Farxiga’s Safety Profile Undented

 
• By Andrew McConaghie
  
Astrazeneca
The investigator-led trial began in April 2020, alongside other trials of drugs repurposed against COVID-19, most of which have failed.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip